Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial.
Raungaard B, Jensen LO, Tilsted HH, Christiansen EH, Maeng M, Terkelsen CJ, Krusell LR, Kaltoft A, Kristensen SD, Bøtker HE, Thuesen L, Aarøe J, Jensen SE, Villadsen AB, Thayssen P, Veien KT, Hansen KN, Junker A, Madsen M, Ravkilde J, Lassen JF; Scandinavian Organization for Randomized Trials with Clinical Outcome (SORT OUT). Raungaard B, et al. Among authors: thayssen p. Lancet. 2015 Apr 18;385(9977):1527-35. doi: 10.1016/S0140-6736(14)61794-3. Epub 2015 Jan 16. Lancet. 2015. PMID: 25601789 Clinical Trial.
Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial.
Galløe AM, Thuesen L, Kelbaek H, Thayssen P, Rasmussen K, Hansen PR, Bligaard N, Saunamäki K, Junker A, Aarøe J, Abildgaard U, Ravkilde J, Engstrøm T, Jensen JS, Andersen HR, Bøtker HE, Galatius S, Kristensen SD, Madsen JK, Krusell LR, Abildstrøm SZ, Stephansen GB, Lassen JF; SORT OUT II Investigators. Galløe AM, et al. Among authors: thayssen p. JAMA. 2008 Jan 30;299(4):409-16. doi: 10.1001/jama.299.4.409. JAMA. 2008. PMID: 18230778 Clinical Trial.
Comparison of stent thrombosis, myocardial infarction, and mortality following drug-eluting versus bare-metal stent coronary intervention in patients with diabetes mellitus.
Maeng M, Jensen LO, Kaltoft A, Hansen HH, Bøttcher M, Lassen JF, Thayssen P, Krusell LR, Rasmussen K, Pedersen L, Sørensen HT, Johnsen SP, Thuesen L. Maeng M, et al. Among authors: thayssen p. Am J Cardiol. 2008 Jul 15;102(2):165-72. doi: 10.1016/j.amjcard.2008.03.034. Epub 2008 May 28. Am J Cardiol. 2008. PMID: 18602515
Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial.
Jensen LO, Maeng M, Thayssen P, Christiansen EH, Hansen KN, Galloe A, Kelbaek H, Lassen JF, Thuesen L. Jensen LO, et al. Among authors: thayssen p. Eur Heart J. 2008 Nov;29(22):2733-41. doi: 10.1093/eurheartj/ehn434. Epub 2008 Oct 2. Eur Heart J. 2008. PMID: 18832385 Free article. Clinical Trial.
Comparison of the sirolimus-eluting versus paclitaxel-eluting coronary stent in patients with diabetes mellitus: the diabetes and drug-eluting stent (DiabeDES) randomized angiography trial.
Maeng M, Jensen LO, Galloe AM, Thayssen P, Christiansen EH, Hansen KN, Helqvist S, Botker HE, Lassen JF, Thuesen L. Maeng M, et al. Among authors: thayssen p. Am J Cardiol. 2009 Feb 1;103(3):345-9. doi: 10.1016/j.amjcard.2008.09.084. Epub 2008 Nov 12. Am J Cardiol. 2009. PMID: 19166687 Clinical Trial.
2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry).
Kaltoft A, Jensen LO, Maeng M, Tilsted HH, Thayssen P, Bøttcher M, Lassen JF, Krusell LR, Rasmussen K, Hansen KN, Pedersen L, Johnsen SP, Sørensen HT, Thuesen L. Kaltoft A, et al. Among authors: thayssen p. J Am Coll Cardiol. 2009 Feb 24;53(8):658-64. doi: 10.1016/j.jacc.2008.09.058. J Am Coll Cardiol. 2009. PMID: 19232897 Free article.
Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction.
Jensen LO, Maeng M, Thayssen P, Kaltoft A, Tilsted HH, Bøttcher M, Lassen JF, Hansen KN, Krusell LR, Rasmussen K, Pedersen KE, Pedersen L, Paaske Johnsen S, Sørensen HT, Thuesen L. Jensen LO, et al. Among authors: thayssen p. Circ Cardiovasc Interv. 2008 Dec;1(3):176-84. doi: 10.1161/CIRCINTERVENTIONS.108.794578. Circ Cardiovasc Interv. 2008. PMID: 20031676
Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial.
Rasmussen K, Maeng M, Kaltoft A, Thayssen P, Kelbaek H, Tilsted HH, Abildgaard U, Christiansen EH, Engstrøm T, Krusell LR, Ravkilde J, Hansen PR, Hansen KN, Abildstrøm SZ, Aarøe J, Jensen JS, Kristensen SD, Bøtker HE, Madsen M, Johnsen SP, Jensen LO, Sørensen HT, Thuesen L, Lassen JF; SORT OUT III study group. Rasmussen K, et al. Among authors: thayssen p. Lancet. 2010 Mar 27;375(9720):1090-9. doi: 10.1016/S0140-6736(10)60208-5. Epub 2010 Mar 16. Lancet. 2010. PMID: 20231034 Clinical Trial.
202 results